LB Abnoba

Company

Business Overview

Taking new steps toward “a happy life” and “the advancement of human welfare” through the spirit of love and service.

Domestic and Global Partnership Experience

LB Abnoba focuses on oncology and immunotherapy based on cognitive medicine, introducing various pharmaceuticals through joint research and technology partnerships with leading global pharmaceutical companies. Through a technology partnership with Germany’ s Abnoba GmbH, we have introduced the natural immune-oncology agent Abnobaviscum to the Korean market. In addition, we supply the non-hormonal menopause prescription drug Klimadophlan Tablets under an exclusive sales agreement with Germany’ s DHU. We have also introduced Lbracan, a breast cancer treatment, as the only domestically manufactured product of its kind in Korea, presenting new possibilities in cancer and immunotherapy. LB Abnoba continues to strengthen strategic partnerships with global pharmaceutical companies to introduce differentiated and innovative new products.

Nationwide Sales Network Covering General and Specialty Hospitals

Leveraging a strong nationwide sales network that spans from general hospitals to local clinics, we strategically penetrate the Korean pharmaceutical market and achieve effective sales expansion.

Pharmaceutical Sales Network and Client Base
Major and General
Hospitals
330
Hospitals
& Clinics
1,500
Care
Hospital
800
Pharmacy
10,000
Cold Chain System for Refrigerated Pharmaceuticals

Placing the highest priority on pharmaceutical quality and safety, we have built and operate a cold chain system that ensures temperature stability throughout the entire distribution process, in collaboration with Korea’ s leading cold chain specialists.

Regulatory Affairs (RA) Capabilities for Pharmaceutical Imports

With strong expertise in regulatory approvals for both domestic and imported pharmaceuticals, as well as herbal and natural medicines, we support rapid product approvals and market entry. By establishing approval strategies that meet global regulatory requirements, we ensure the stable launch of both new drugs and generics, while sustaining long-term market presence.

Business Strategy

Business Strategy
  • Development of differentiated, high-quality pharmaceuticals

  • Strengthening competitiveness through enhanced technology partnerships

  • Focus on addressing unmet medical needs

  • Expanding sustainable growth drivers

Co-Promotion and
Product Introduction Proposals

LB Abnoba actively engages in co-promotion and product introduction partnerships with domestic and global pharmaceutical companies.

  • Joint marketing based on a nationwide distribution network and market expertise

  • Strategic entry into and sales expansion within the Korean pharmaceutical market through a robust nationwide sales network

  • Partnership opportunities for the introduction of global innovative drugs into the Korean market

Partnership
Proposal bd@lbifamily.com